A unified mathematical model of thyroid hormone regulation and implication for personalized treatment of thyroid disorders. (7th November 2021)

• Record Type: Journal Article
• Authors: Yang, Boya; Tang, Xi; Haller, Michael J.; Schatz, Desmond A.; Rong, Libin
• Is Part Of: Journal of theoretical biology. Volume 528(2021)
• Publication Date: 2021-11-07
• Subjects: Thyroid hormone regulation -- Mathematical model -- Drug intervention -- Hashimoto's thyroiditis -- Graves' disease; Biology -- Periodicals; Biological Science Disciplines -- Periodicals; Biology -- Periodicals; Biologie -- Périodiques; Theoretische biologie; Biology; Periodicals; 571.05
• DOI: 10.1016/j.jtbi.2021.110853
• Languages: English
• ISSNs: 0022-5193

Abstract

Highlights: We develop a mathematical model of thyroid hormone regulation. The model can explain different thyroid disorders. The model may hel.p develop personalized treatment. Abstract: Current clinician practice for thyroid hormone regulation of patients is based upon guesswork and experience rather than quantified analysis, which exposes patients under longer risk and discomfort. To quantitatively analyze the thyroid regulation for patients of different thyroid states, we develop a two-dimensional mathematical model that can be applied to analyze the dynamic behaviors of thyroid hormones with or without drug intervention. The unified model can be employed to study the regulation of TSH (thyroid-stimulating hormone) and FT4 (free thyroxine) for euthyroid (normal thyroid) subjects, Hashimoto's thyroiditis, and Graves' disease patients, respectively. The results suggest that the level of TPOAb (thyroid peroxidase antibody) may be a factor determining whether the patient would progress from euthyroid state to subclinical or clinical hypothyroidism, and that increased TRAb (TSH receptor antibody) may lead Graves' disease to deteriorate from the early stage to overt hyperthyroidism. Given the early blood-test data, we demonstrate the feasibility for healthcare professionals to apply our model in choosing an appropriate dosage regimen for patients to achieve the desired TSH and FT4 levels within a specified time frame. This proposed model has the potential to optimize personalized treatment and shorten the therapeutic time for patients suffering from Hashimoto's thyroiditis and Graves' disease.